26172-55-4
CAS 26172-55-4
26172-55-4 (CAS 26172-55-4) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| METHYLCHLOROISOTHIAZOLINONE | 1367119 | SU | MTHSPL |
| Methylchloroisothiazolinone | 1367119 | SU | MTHSPL |
| methylchloroisothiazolinone | 1367119 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is 26172-55-4 used for in pharmaceutical contexts?
26172-55-4 (CAS 26172-55-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for 26172-55-4?
No adverse-event association or SIDER side-effect rows are rendered for 26172-55-4 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is 26172-55-4 also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Methylchloroisothiazolinone with EU status "restricted".
What clinical phase is 26172-55-4 in?
No phase 1-4 clinical development badge is rendered for 26172-55-4 because the matched compound identifier rows do not contain a max-phase value.